The following bids, mergers, acquisitions and disposals were reported by 1930 GMT on Thursday:
** Angelini Pharma said it would acquire U.S. rare-disease drug maker Catalyst Pharmaceuticals in a $4.1 billion deal, marking the Italian drugmaker's entry into the U.S. pharmaceutical market.
** Swiss pharmaceutical giant Roche said it had agreed to acquire U.S.-based digital pathology and AI-powered technology firm PathAI in a deal worth $750 million upfront plus further milestone payments of up to $300 million.
** Mexico's Grupo Carso said on Wednesday that it has signed a binding agreement with Harbour Energy to acquire, via a subsidiary, an additional 5% stake in the Zama oilfield in the Gulf of Mexico for $75.25 million.
** Western Midstream Partners said on Wednesday it would acquire privately held Brazos Delaware II in a $1.6 billion deal, expanding its gathering and processing footprint in the core of the Permian Basin.
** Britain's Intertek is set to reject EQT's sweetened 58-pound-per-share offer ($78.85), the Financial Times reported on Wednesday, citing people familiar with the matter.
** Bucharest-listed Premier Energy has agreed to buy Evryo Group's power distribution network from Australia's Macquarie for about 700 million euros ($824.39 million), the companies said on Friday.
** United Arab Emirates real estate developer Arada, backed by Gulf royals, said on Thursday it had acquired a majority stake in Abu Dhabi-based healthcare provider Reem Hospital as part of a $545 million investment, marking its entry into the sector.
** Recreational yacht retailer MarineMax NYSE:HZO is preparing to sell itself as one potential buyer recently raised its offer and at least one prominent private equity firm is conducting due diligence, three sources told Reuters.